Comprehensive Characterization of Islet Remodeling in Development and in Diabetes Using Mass Cytometry.

Endocrinology

Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.

Published: July 2024

The pancreatic islet is the functional and structural unit of the pancreatic endocrine portion. Islet remodeling occurs in both normal development and pathogenesis of type 1 (T1D) and type 2 diabetes (T2D). However, accurately quantifying changes in islet cellular makeup and hormone expressions poses significant challenges due to large intra- and inter-donor heterogeneity and the limited scalability of traditional methods such as immunostaining. The cytometry by time-of-flight (CyTOF) technology enables simultaneous quantification of more than 30 protein markers at single-cell resolution in a high-throughput fashion. Moreover, with distinct DNA and viability markers, single live cells can be explicitly selected in CyTOF. Here, leveraging the CyTOF data generated by the Human Pancreas Analysis Program, we characterized more than 12 million islet cells from 71 donors. Our data revealed continued age-related changes in islet endocrine cell compositions, but the maturity of endocrine cells is reached by 3 years of age. We also observed significant changes in beta cell numbers and key protein expressions, along with a significant increase in bihormonal cells in T1D donors. In contrast, T2D donors exhibited minimal islet remodeling events. Our data shine a light on the islet dynamics during development and diabetes pathogenesis and suggest divergent pathogenesis processes of T1D and T2D. Our comprehensive approach not only elucidates islet plasticity but also establishes a foundation for integrated CyTOF analysis in islet biology and beyond.

Download full-text PDF

Source
http://dx.doi.org/10.1210/endocr/bqae094DOI Listing

Publication Analysis

Top Keywords

islet remodeling
12
islet
10
development diabetes
8
changes islet
8
comprehensive characterization
4
characterization islet
4
remodeling development
4
diabetes mass
4
mass cytometry
4
cytometry pancreatic
4

Similar Publications

CFTR represses a PDX1 axis to govern pancreatic ductal cell fate.

iScience

December 2024

Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

Inflammation, acinar atrophy, and ductal hyperplasia drive pancreatic remodeling in newborn cystic fibrosis (CF) ferrets lacking a functional cystic fibrosis conductance regulator (CFTR) channel. These changes are associated with a transient phase of glucose intolerance that involves islet destruction and subsequent regeneration near hyperplastic ducts. The phenotypic changes in CF ductal epithelium and their impact on islet function are unknown.

View Article and Find Full Text PDF

Protocol for isolation and transplantation of rat pancreatic islets in the kidney capsule to treat diabetes.

STAR Protoc

December 2024

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Clinical Stem Cell Research Center, Peking University Third Hospital, Peking University, Beijing 100191, China. Electronic address:

Article Synopsis
  • * The text outlines a method for creating a diabetes model and isolating islets using a perfusion technique, gradient centrifugation, and culturing in RPMI 1640 for recovery.
  • * Successful transplantation of rat islets into diabetic nude mice showed that this method is effective for achieving functional recovery in islet function.
View Article and Find Full Text PDF

Background: Knockout (KO) ferrets with the cystic fibrosis transmembrane conductance regulator (CFTR) exhibit distinct phases of dysglycemia and pancreatic remodeling prior to cystic fibrosis-related diabetes (CFRD) development. Following normoglycemia during the first month of life (Phase l), hyperglycemia occurs during the subsequent 2 months (Phase Il) with decreased islet mass, followed by a period of near normoglycemia (Phase Ill) in which the islets regenerate. We aimed to characterize islet hormone expression patterns across these Phases.

View Article and Find Full Text PDF

Progress in Biomaterials-Enhanced Vascularization by Modulating Physical Properties.

ACS Biomater Sci Eng

November 2024

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Clinical Stem Cell Research Center, Peking University Third Hospital, Peking University, Beijing 100191, China.

Article Synopsis
  • Sufficient blood flow and a good vascular system are essential for delivering nutrients and oxygen in biomaterials used for medical purposes.
  • Exploring the best physical properties of these biomaterials, like pore structure and stiffness, can enhance their ability to develop blood vessels, improving their effectiveness in tissue engineering.
  • Understanding these properties can help create better research models and personalized treatments for issues like bone regeneration, wound healing, islet transplantation, and heart repair.
View Article and Find Full Text PDF

Unlabelled: We have reported that the microtubule (MT) network in β cells attenuates this function by withdrawing insulin secretory granules (ISGs) away from the plasma membrane. Thus, high glucose-induced MT remodeling is required for robust glucose-stimulated insulin secretion (GSIS). We now show that α-cell secreted hormones, Gcg and/or Glp1, regulate the MT stability in β cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!